BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3311Biotechnology
$47.99 +$1.88 (+4.08%)
Pre-market · Oct 8, 8:40 am ET · After hours $47.00 -2.06%
Open$45.64
Prev close$46.11
Day range$45.22 – $48.15
Volume232.6K
Market cap$896.45M
P/E (TTM)2.8
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$78.70M-22.6% YoY
Operating profit$23.58M-61.4% YoY
Net profit$17.29M-71.0% YoY
Diluted EPS$0.88-73.2% YoY
Free cash flow-$39.69M-230.0% YoY
Operating cash flow$30.65M

Revenue, last 8 quarters

$55.3MSep '24$57.6MDec '24$53.3MMar '25$101.7MJun '25$69.5MSep '25$69.8MDec '25$58.8MMar '26$78.7MJun '26

Net profit, last 8 quarters

$12.4MSep '24$14.3MDec '24$11.4MMar '25$59.6MJun '25$27.9MSep '25$268.1MDec '25$8.7MMar '26$17.3MJun '26

Diluted EPS by quarter

0.70Sep '240.80Dec '240.63Mar '253.28Jun '251.46Sep '2513.54Dec '250.44Mar '260.88Jun '26

Free cash flow by quarter

$21.7MSep '24$14.5MDec '24$-893.0KMar '25$30.5MJun '25$24.0MSep '25$22.0MDec '25$2.7MMar '26$-39.7MJun '26

Annual revenue

$108.6MFY20$149.2MFY21$120.2MFY22$116.9MFY23$179.3MFY24$294.3MFY25

Profitability & balance sheet

Gross margin91.4%
Operating margin31.5%
Net margin116.3%
Return on equity126.9%
Return on assets88.5%
Return on invested capital106.1%
Current ratio1.94
Liabilities / assets18.4%
Cash & investments$95.33M
Total debt$39.29M
Net cash (debt)$56.04M
Free cash flow / sales3.3%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $78.70M $58.82M $294.28M $69.80M $69.46M
Total Operating Revenue $78.70M $58.82M $294.28M $69.80M $69.46M
Cost of Revenue $8.53M $4.61M $19.62M $5.96M $4.75M
Gross Profit $70.18M $54.21M $274.66M $63.85M $64.71M
Operating Expense $46.60M $42.33M $149.20M $40.68M $36.29M
Selling and Admin Expenses $32.64M $30.65M $115.90M $29.99M $28.94M
Research & Development $13.96M $11.68M $33.30M $10.69M $7.35M
Operating Profit $23.58M $11.89M $125.47M $23.17M $28.42M
Net Non-Operating Interest Income (Expense) $10,000.00 -$228,000.00 -$3.64M -$456,000.00 -$800,000.00
Non-Operating Interest Income $789,000.00 $1.21M $3.68M $1.24M $1.09M
Non-Operating Interest Expense $779,000.00 $1.43M $7.32M $1.70M $1.89M
Pretax Profit $23.59M $11.66M $121.83M $22.71M $27.62M
Tax $6.30M $3.00M -$245.20M -$245.35M -$280,000.00
Net Profit $17.29M $8.65M $367.02M $268.07M $27.90M
Profit from Continuing Operations $17.29M $8.65M $367.02M $268.07M $27.90M
Net Income to Parent Company $17.29M $8.65M $367.02M $268.07M $27.90M
Net Income to Common Stockholders $17.29M $8.65M $367.02M $268.07M $27.90M
Basic EPS $0.93 $0.47 $20.40 $14.72 $1.55
Diluted EPS $0.88 $0.44 $19.48 $13.54 $1.46

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $521.07M $504.61M $513.59M $513.59M $242.53M
Total Current Assets $185.53M $234.03M $240.17M $240.17M $214.93M
Cash and Cash Equivalents & Short-Term Investments $95.33M $146.68M $154.96M $154.96M $137.14M
-Cash and Cash Equivalents $60.82M $24.41M $40.58M $40.58M $48.53M
-Short Term Investments $34.51M $122.27M $114.38M $114.38M $88.61M
Receivables $56.04M $49.95M $51.76M $51.76M $45.93M
-Accounts Receivable $56.04M $49.95M $51.76M $51.76M $45.93M
Prepaid Assets $14.77M $18.61M $16.74M $16.74M $12.69M
Inventory $14.37M $11.65M $11.51M $11.51M $13.30M
Other Current Assets $5.03M $7.14M $5.21M $5.21M $5.86M
Total Non-Current Assets $335.54M $270.58M $273.43M $273.43M $27.61M
Net PPE $647,000.00 $785,000.00 $920,000.00 $920,000.00 $1.10M
-Gross PPE $647,000.00 $785,000.00 $920,000.00 $920,000.00 $1.10M
Goodwill and Other Intangible Assets $93.88M $24.16M $24.75M $24.75M $25.34M
Non-Current Deferred Assets $238.07M $243.28M $245.85M $245.85M –
Other Non-Current Assets $2.94M $2.36M $1.91M $1.91M $1.17M
Total Liabilities $95.64M $104.71M $122.11M $122.11M $124.93M
Total Current Liabilities $95.59M $89.49M $99.24M $99.24M $94.40M
Payables $4.01M $4.49M $7.19M $7.19M $3.85M
-Accounts Payable $4.01M $4.49M $7.19M $7.19M $3.85M
Current Accrued Expenses $14.88M $15.42M $15.64M $15.64M $13.76M
Short-Term Debt and Capital Lease Obligation $39.89M $30.50M $30.43M $30.43M $30.36M
-Current Debt $39.24M $29.87M $29.81M $29.81M $29.76M
-Current Capital Lease Obligation $656,000.00 $636,000.00 $614,000.00 $614,000.00 $594,000.00
Current Deferred Liabilities $27.97M $28.08M $29.07M $29.07M $31.38M
Other Current Liabilities $218,000.00 $5.00M $5.00M $5.00M $5.00M
Total Non-Current Liabilities $58,000.00 $15.22M $22.88M $22.88M $30.53M
Long Term Debt and Capital Lease Obligation $58,000.00 $15.22M $22.88M $22.88M $30.53M
-Long Term Capital Lease Obligation $58,000.00 $228,000.00 $395,000.00 $395,000.00 $556,000.00
Total Equity $425.42M $399.90M $391.48M $391.48M $117.61M
Stockholders' Equity $425.42M $399.90M $391.48M $391.48M $117.61M
Capital Stock $18,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
-Common Stock $18,000.00 $18,000.00 $18,000.00 $18,000.00 $18,000.00
Additional Paid-In Capital $1.42B $1.41B $1.41B $1.41B $1.41B
Retained Earnings -$997.10M -$1.01B -$1.02B -$1.02B -$1.29B
Gains/Losses Not Affecting Retained Earnings -$148,000.00 -$128,000.00 $181,000.00 $181,000.00 $96,000.00
-Long Term Debt – $14.99M $22.48M $22.48M $29.97M
-Preferred Stock – – $0.00 $0.00 –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $30.65M $2.73M $75.66M $21.98M $24.03M
Net cash flow from continuing operations $30.65M $2.73M $75.66M $21.98M $24.03M
Net Income from Continuing Operations $17.29M $8.65M $367.02M $268.07M $27.90M
Depreciation & Depletion & Amortization $848,000.00 $597,000.00 $2.42M $601,000.00 $603,000.00
Deferred Tax $5.21M $2.57M -$245.85M – –
Change in Working Capital $286,000.00 -$12.39M -$19.51M -$3.34M -$7.37M
-Change in Receivables -$6.10M $1.82M -$10.15M -$5.84M -$6.02M
-Change in Inventory -$3.26M -$581,000.00 -$5.64M $1.13M $188,000.00
-Change in Prepaid Assets $5.97M -$3.79M -$11.85M -$3.39M -$1.87M
-Change in Payables and Accrued Expense $1.19M -$4.28M $5.30M $5.51M -$2.40M
-Change in Other Current Assets $138,000.00 $135,000.00 -$674,000.00 $130,000.00 $128,000.00
-Change in Other Current Liabilities -$150,000.00 -$145,000.00 $439,000.00 -$426,000.00 -$81,000.00
-Change In Other Working Capital $2.50M -$5.54M $3.05M -$455,000.00 $2.69M
Net cash flow from investing $17.45M -$7.98M -$92.37M -$25.36M -$33.18M
Net Cash Flow from Continuing Investing Activities $17.45M -$7.98M -$92.37M -$25.36M -$33.18M
Net Investment Purchase and Sale $87.80M -$7.98M -$92.37M -$25.37M -$33.16M
Financing Cash Flow -$11.70M -$10.92M $601,000.00 -$4.57M $4.27M
Net Cash Flow from Continuing Financing Activities -$11.70M -$10.92M $601,000.00 -$4.57M $4.27M
Net Issuance Payments Of Debt -$7.75M -$7.50M -$7.50M – –
Net Common Stock Issuance -$511,000.00 -$3.74M $0.00 – –
Proceeds from Stock Option Exercised $1.86M $321,000.00 $8.10M $2.93M $4.27M
Ending Cash Balance $60.87M $24.47M $40.64M $40.64M $48.59M
Net Change in Cash $36.41M -$16.17M -$16.11M -$7.95M -$4.87M
Beginning Cash Balance $24.47M $40.64M $56.75M $48.59M $53.46M
Free Cash Flow -$39.69M $2.73M $75.66M $21.99M $24.02M
Other Non-Cash Items – – -$39.98M $0.00 $0.00
Capital Expenditure – – $0.00 $12,000.00 –
Net PPE Purchase and Sale – – $0.00 $0.00 –
Net Intangibles Purchase and Sale – – $0.00 $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on RIGL.

Leave a comment

Scroll to Top